Ocugen Inc (NASDAQ: OCGN) on Tuesday, plunged -0.67% from the previous trading day, before settling in for the closing price of $0.89. Within the past 52 weeks, OCGN’s price has moved between $0.36 and $2.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 8.52% annually for the last half of the decade. The company achieved an average annual earnings per share of 22.12%. With a float of $287.08 million, this company’s outstanding shares have now reached $290.26 million.
In an organization with 65 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.72%, operating margin of -531.15%, and the pretax margin is -532.51%.
Ocugen Inc (OCGN) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ocugen Inc is 1.45%, while institutional ownership is 27.54%. The most recent insider transaction that took place on Nov 26 ’24, was worth 9,095. In this transaction Director of this company bought 10,000 shares at a rate of $0.91, taking the stock ownership to the 10,000 shares. Before that another transaction happened on Nov 22 ’24, when Company’s Director bought 25,000 for $0.91, making the entire transaction worth $22,848. This insider now owns 75,000 shares in total.
Ocugen Inc (OCGN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.12% per share during the next fiscal year.
Ocugen Inc (NASDAQ: OCGN) Trading Performance Indicators
Ocugen Inc (OCGN) is currently performing well based on its current performance indicators. A quick ratio of 2.58 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 54.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.18, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.26 in one year’s time.
Technical Analysis of Ocugen Inc (OCGN)
Let’s dig in a bit further. During the last 5-days, its volume was 4.02 million. That was inferior than the volume of 5.96 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 15.14%. Additionally, its Average True Range was 0.06.
During the past 100 days, Ocugen Inc’s (OCGN) raw stochastic average was set at 4.69%, which indicates a significant decrease from 23.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.56% in the past 14 days, which was lower than the 68.57% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9462, while its 200-day Moving Average is $1.3004. However, in the short run, Ocugen Inc’s stock first resistance to watch stands at $0.9181. Second resistance stands at $0.9529. The third major resistance level sits at $0.9910. If the price goes on to break the first support level at $0.8452, it is likely to go to the next support level at $0.8071. The third support level lies at $0.7723 if the price breaches the second support level.
Ocugen Inc (NASDAQ: OCGN) Key Stats
Market capitalization of the company is 257.29 million based on 291,320K outstanding shares. Right now, sales total 6,040 K and income totals -63,080 K. The company made 1,140 K in profit during its latest quarter, and -12,970 K in sales during its previous quarter.
